1	4	11	Italian	italian	JJ	_	_	B-cesDoc	B-p
2	12	20	chemical	chemical	NN	_	_	I-cesDoc	I-p
3	21	26	giant	giant	NN	_	_	I-cesDoc	I-p
4	27	37	Montedison	montedison	NNP	_	_	I-cesDoc	I-p
5	38	40	S.	S.	NN	_	_	I-cesDoc	I-p
6	40	42	p.	p.	NN	_	_	I-cesDoc	I-p
7	43	45	A.	A.	NN	_	_	I-cesDoc	I-p
8	45	46	,	,	,	_	_	I-cesDoc	I-p
9	47	54	through	through	IN	_	_	I-cesDoc	I-p
10	55	58	its	its	PRP$	_	_	I-cesDoc	I-p
11	59	69	Montedison	montedison	NNP	_	_	I-cesDoc	I-p
12	70	81	Acquisition	acquisition	NNP	_	_	I-cesDoc	I-p
13	82	86	N.V.	N.V.	NN	_	_	I-cesDoc	I-p
14	87	95	indirect	indirect	JJ	_	_	I-cesDoc	I-p
15	96	100	unit	unit	NN	_	_	I-cesDoc	I-p
16	100	101	,	,	,	_	_	I-cesDoc	I-p
17	102	107	began	begin	VBD	_	_	I-cesDoc	I-p
18	108	111	its	its	PRP$	_	_	I-cesDoc	I-p
19	112	113	$	$	$	_	_	I-cesDoc	I-p
20	113	115	37	37	CD	_	_	I-cesDoc	I-p
21	115	116	-	-	-	_	_	I-cesDoc	I-p
22	116	117	a	a	DT	_	_	I-cesDoc	I-p
23	117	118	-	-	-	_	_	I-cesDoc	I-p
24	118	123	share	share	NN	_	_	I-cesDoc	I-p
25	124	130	tender	tender	NN	_	_	I-cesDoc	I-p
26	131	136	offer	offer	NN	_	_	I-cesDoc	I-p
27	137	140	for	for	IN	_	_	I-cesDoc	I-p
28	141	144	all	all	PDT	_	_	I-cesDoc	I-p
29	145	148	the	the	DT	_	_	I-cesDoc	I-p
30	149	155	common	common	JJ	_	_	I-cesDoc	I-p
31	156	162	shares	shares	NNS	_	_	I-cesDoc	I-p
32	163	174	outstanding	outstanding	JJ	_	_	I-cesDoc	I-p
33	175	177	of	of	IN	_	_	I-cesDoc	I-p
34	178	186	Erbamont	erbamont	NNP	_	_	I-cesDoc	I-p
35	187	191	N.V.	N.V.	NN	_	_	I-cesDoc	I-p
36	191	192	,	,	,	_	_	I-cesDoc	I-p
37	193	194	a	a	DT	_	_	I-cesDoc	I-p
38	195	200	maker	maker	NN	_	_	I-cesDoc	I-p
39	201	203	of	of	IN	_	_	I-cesDoc	I-p
40	204	219	pharmaceuticals	pharmaceutical	NNS	_	_	I-cesDoc	I-p
41	220	232	incorporated	incorporate	VBN	_	_	I-cesDoc	I-p
42	233	235	in	in	IN	_	_	I-cesDoc	I-p
43	236	239	the	the	DT	_	_	I-cesDoc	I-p
44	240	251	Netherlands	netherlands	NNP	_	_	I-cesDoc	I-p
45	251	252	.	.	.	_	_	I-cesDoc	I-p
46	256	259	The	the	DT	_	_	I-cesDoc	B-p
47	260	265	offer	offer	NN	_	_	I-cesDoc	I-p
48	265	266	,	,	,	_	_	I-cesDoc	I-p
49	267	277	advertised	advertise	VBN	_	_	I-cesDoc	I-p
50	278	280	in	in	IN	_	_	I-cesDoc	I-p
51	281	286	today	today	NN	_	_	I-cesDoc	I-p
52	286	288	's	's	POS	_	_	I-cesDoc	I-p
53	289	297	editions	edition	NNS	_	_	I-cesDoc	I-p
54	298	300	of	of	IN	_	_	I-cesDoc	I-p
55	301	304	The	the	DT	_	_	I-cesDoc	I-p
56	305	309	Wall	wall	NNP	_	_	I-cesDoc	I-p
57	310	316	Street	street	NNP	_	_	I-cesDoc	I-p
58	317	324	Journal	journal	NNP	_	_	I-cesDoc	I-p
59	324	325	,	,	,	_	_	I-cesDoc	I-p
60	326	328	is	be	VBZ	_	_	I-cesDoc	I-p
61	329	338	scheduled	schedule	VBN	_	_	I-cesDoc	I-p
62	339	341	to	to	TO	_	_	I-cesDoc	I-p
63	342	348	expire	expire	VB	_	_	I-cesDoc	I-p
64	349	351	at	at	IN	_	_	I-cesDoc	I-p
65	352	355	the	the	DT	_	_	I-cesDoc	I-p
66	356	359	end	end	NN	_	_	I-cesDoc	I-p
67	360	362	of	of	IN	_	_	I-cesDoc	I-p
68	363	371	November	november	NNP	_	_	I-cesDoc	I-p
69	371	372	.	.	.	_	_	I-cesDoc	I-p
70	376	386	Montedison	montedison	NNP	_	_	I-cesDoc	B-p
71	387	396	currently	currently	RB	_	_	I-cesDoc	I-p
72	397	401	owns	own	VBZ	_	_	I-cesDoc	I-p
73	402	407	about	about	IN	_	_	I-cesDoc	I-p
74	408	410	72	72	CD	_	_	I-cesDoc	I-p
75	410	411	%	%	NN	_	_	I-cesDoc	I-p
76	412	414	of	of	IN	_	_	I-cesDoc	I-p
77	415	423	Erbamont	erbamont	NNP	_	_	I-cesDoc	I-p
78	423	425	's	's	POS	_	_	I-cesDoc	I-p
79	426	432	common	common	JJ	_	_	I-cesDoc	I-p
80	433	439	shares	shares	NNS	_	_	I-cesDoc	I-p
81	440	451	outstanding	outstanding	JJ	_	_	I-cesDoc	I-p
82	451	452	.	.	.	_	_	I-cesDoc	I-p
83	456	459	The	the	DT	_	_	I-cesDoc	B-p
84	460	465	offer	offer	NN	_	_	I-cesDoc	I-p
85	466	468	is	be	VBZ	_	_	I-cesDoc	I-p
86	469	474	being	be	VBG	_	_	I-cesDoc	I-p
87	475	483	launched	launch	VBN	_	_	I-cesDoc	I-p
88	484	492	pursuant	pursuant	JJ	_	_	I-cesDoc	I-p
89	493	495	to	to	TO	_	_	I-cesDoc	I-p
90	496	497	a	a	DT	_	_	I-cesDoc	I-p
91	498	508	previously	previously	RB	_	_	I-cesDoc	I-p
92	509	518	announced	announce	VBN	_	_	I-cesDoc	I-p
93	519	528	agreement	agreement	NN	_	_	I-cesDoc	I-p
94	529	536	between	between	IN	_	_	I-cesDoc	I-p
95	537	540	the	the	DT	_	_	I-cesDoc	I-p
96	541	550	companies	company	NNS	_	_	I-cesDoc	I-p
97	550	551	.	.	.	_	_	I-cesDoc	I-p

